104 related articles for article (PubMed ID: 38741395)
1. Effects of rosiglitazone on quality of life and prognosis of patients with early stage glottic laryngeal carcinoma.
Tu P; Lv Y; Cai L
Pak J Pharm Sci; 2024 Jan; 37(1):9-15. PubMed ID: 38741395
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Radiotherapy Omitting Level Ⅳ for Locally Advanced Supraglottic and Glottic Laryngeal Carcinoma.
Wu Y; Zhang L; Tang T; Li L; Li L; Yu H
Technol Cancer Res Treat; 2021; 20():1533033820985876. PubMed ID: 33517858
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure for early-stage glottic carcinoma: 10 years' experience in conformal radiotherapy era.
Sert F; Kaya I; Ozturk K; Esassolak M
J Cancer Res Ther; 2019; 15(3):576-581. PubMed ID: 31169223
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of early laryngeal cancer].
Nagatani G; Mori T; Udaka T; Shiomori T; Ohbuchi T; Suzuki H
Nihon Jibiinkoka Gakkai Kaiho; 2007 Jun; 110(6):447-52. PubMed ID: 17633113
[TBL] [Abstract][Full Text] [Related]
5. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
6. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of cervical lymphatic metastasis to prognosis of glottic carcinoma: a report of 333 cases].
Zhang Q; Lai FY; Guo ZM; Zeng ZY; Song M; Yu WB; Yang CS
Ai Zheng; 2007 Oct; 26(10):1138-42. PubMed ID: 17927888
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of window partial laryngectomy for stage T2-3 glottic laryngeal carcinoma.
Wang S; Yang C; Li C; Lin X; Yang D; Chen E; Zeng Y
J Voice; 2011 Jan; 25(1):124-8. PubMed ID: 20171837
[TBL] [Abstract][Full Text] [Related]
9. [Treatment and prognosis of stage IV glottic laryngeal cancer].
Lai FY; Zhang Q; Guo ZM; Zeng ZY; Li H; Yu WB; Yang CS
Ai Zheng; 2008 Jan; 27(1):71-4. PubMed ID: 18184468
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
11. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
[TBL] [Abstract][Full Text] [Related]
12. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
13. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
14. Oncological outcome after CO2 laser cordectomy for early-stage glottic carcinoma.
Bocciolini C; Presutti L; Laudadio P
Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):86-93. PubMed ID: 16116830
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of therapeutic effect and prognostic factors on early glottic carcinoma.
Peng Z; Li Y; Jin L; Tao X; Cai X; Feng J; Liu R; Zhang Q; Li L
Photodiagnosis Photodyn Ther; 2016 Sep; 15():167-71. PubMed ID: 27378675
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of cervical lymphatic metastasis to prognosis of T3-T4 glottic cancer].
Yu WB; Zeng ZY; Chen FJ; Zhang Q; Guo ZM; Li H; Liu XK; Wu GH
Ai Zheng; 2006 Oct; 25(10):1271-4. PubMed ID: 17059774
[TBL] [Abstract][Full Text] [Related]
17. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
[TBL] [Abstract][Full Text] [Related]
18. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.
Kalfert D; Celakovsky P; Laco J; Ludvikova M
Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498
[TBL] [Abstract][Full Text] [Related]
19. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
